First Experiences with Amyloid-Related Imaging Abnormalities — Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management - 21/11/24
Doi : 10.14283/jpad.2024.8
Poul F. Høilund-Carlsen 1, 2, ⁎ 
, G. Perry 3, A. Alavi 4, J.R. Barrio 5
, G. Perry 3, A. Alavi 4, J.R. Barrio 5 1 Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark
2 Department of Clinical Research, University of Southern Denmark, 19 J.B. Winsløws Vej, 5000, Odense C, Denmark
3 Department of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX, USA
4 Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
5 Department of Molecular and Medical Pharmacology, David Geffen UCLA School of Medicine, Los Angeles, CA, USA
a pfhc@rsyd.dk pfhc@rsyd.dk
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
© 2023
THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 11 - N° 1
P. 259-260 - Gennaio 2024 Ritorno al numero
Articolo precedente
- Oral Health as a Risk Factor for Alzheimer Disease
- S.M. Pruntel, B.C. van Munster, J.J. de Vries, A. Vissink, Anita Visser
- Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment
- Matthew D. Howe, M.C. Riddle, S.P. Salloway
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.